BR9205609A - Processo ortomolecular de tratamento de doença falciforme - Google Patents

Processo ortomolecular de tratamento de doença falciforme

Info

Publication number
BR9205609A
BR9205609A BR9205609A BR9205609A BR9205609A BR 9205609 A BR9205609 A BR 9205609A BR 9205609 A BR9205609 A BR 9205609A BR 9205609 A BR9205609 A BR 9205609A BR 9205609 A BR9205609 A BR 9205609A
Authority
BR
Brazil
Prior art keywords
orthomolecular
treatment
sickle cell
cell disease
disease
Prior art date
Application number
BR9205609A
Other languages
English (en)
Inventor
Michael Wilburn
Original Assignee
Michael Wilburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Wilburn filed Critical Michael Wilburn
Publication of BR9205609A publication Critical patent/BR9205609A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9205609A 1991-02-08 1992-01-31 Processo ortomolecular de tratamento de doença falciforme BR9205609A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/652,773 US5108754A (en) 1991-02-08 1991-02-08 Orthomolecular method of treating sickle cell disease
PCT/US1992/000450 WO1992013522A1 (en) 1991-02-08 1992-01-31 Orthomolecular method of treating sickle cell disease

Publications (1)

Publication Number Publication Date
BR9205609A true BR9205609A (pt) 1994-07-26

Family

ID=24618098

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9205609A BR9205609A (pt) 1991-02-08 1992-01-31 Processo ortomolecular de tratamento de doença falciforme

Country Status (15)

Country Link
US (1) US5108754A (pt)
EP (1) EP0571474B1 (pt)
JP (1) JPH06507382A (pt)
KR (1) KR100221118B1 (pt)
AP (1) AP275A (pt)
AT (1) ATE175204T1 (pt)
AU (1) AU662124B2 (pt)
BR (1) BR9205609A (pt)
CA (1) CA2103580C (pt)
DE (1) DE69228054T2 (pt)
DK (1) DK0571474T3 (pt)
ES (1) ES2125887T3 (pt)
GR (1) GR3029742T3 (pt)
IL (1) IL100663A (pt)
WO (1) WO1992013522A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
HUT72422A (en) * 1994-04-20 1996-04-29 Beres Export Import Rt Aquous concentrate and process for its preparation
US5626884A (en) * 1995-08-18 1997-05-06 Lockett; Curtis G. Treatment of sickle cell disease
US5693671A (en) * 1996-05-01 1997-12-02 Harbor-Ucla Research And Education Institute L-glutamine therapy for sickle cell diseases and thalassemia
US20080153761A1 (en) * 1998-04-08 2008-06-26 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
KR20020088498A (ko) * 2001-05-17 2002-11-29 (주)미토콘 에스-아데노실메티오닌을 유효성분으로 함유하는 인슐린저항증 개선용 조성물
DE10243234A1 (de) * 2002-09-17 2004-03-25 Phenion Gmbh & Co. Kg Tocopherylester
WO2005007173A1 (en) * 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US8840950B2 (en) 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
CN107075441A (zh) * 2014-07-30 2017-08-18 卡斯西部储备大学 诊断血红蛋白病症和监测血细胞的生物芯片
EP3204004A4 (en) * 2014-10-08 2018-05-30 Epigenetics Pharma LLC Vitamin e-nucleoside prodrugs
WO2016196281A1 (en) * 2015-06-01 2016-12-08 Nanometics Llc Mtap inhibitors for the treatment of sickle cemtap disease
US10349589B2 (en) 2016-09-08 2019-07-16 Hemex Health, Inc. Diagnostics systems and methods
EP3510396B1 (en) 2016-09-08 2021-12-08 Hemex Health, Inc. Diagnostics system
KR20190092778A (ko) 2018-01-31 2019-08-08 양원용 태양광을 이용한 기능성 전동식 농약분무기
US11740203B2 (en) 2019-06-25 2023-08-29 Hemex Health, Inc. Diagnostics systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL57609A (en) * 1979-06-21 1983-05-15 Yeda Res & Dev Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease

Also Published As

Publication number Publication date
AU1250592A (en) 1992-09-07
CA2103580C (en) 2002-11-26
AP9200358A0 (en) 1992-04-30
JPH06507382A (ja) 1994-08-25
US5108754A (en) 1992-04-28
AP275A (en) 1993-07-18
EP0571474A1 (en) 1993-12-01
AU662124B2 (en) 1995-08-24
KR100221118B1 (ko) 1999-09-15
ES2125887T3 (es) 1999-03-16
CA2103580A1 (en) 1992-08-09
EP0571474A4 (pt) 1994-02-09
IL100663A0 (en) 1992-09-06
IL100663A (en) 1995-10-31
WO1992013522A1 (en) 1992-08-20
EP0571474B1 (en) 1998-12-30
ATE175204T1 (de) 1999-01-15
DK0571474T3 (da) 1999-08-30
DE69228054D1 (de) 1999-02-11
DE69228054T2 (de) 1999-08-05
GR3029742T3 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
BR9205609A (pt) Processo ortomolecular de tratamento de doença falciforme
BR8900379A (pt) Processo para tratamento de lama de aguas servidas
ITPD910102A0 (it) Processo per la preparazione di microsfere contenenti componenti biologicamente attivi
PT90637A (pt) Processo de preparacao de polianidridos
DK0434279T3 (da) Behandling af fjerkræ
KR890004737A (ko) 질병 치료용 자석
IT1246357B (it) Processo per la preparazione di composti perfluoroalcossisolfonici
BR8804491A (pt) Processo de preparacao de policarbonato
IT1230108B (it) Filtro di processo
BR8705545A (pt) Processo de preparacao de composto
BR9101496A (pt) Processo para tratamento de tecidos
PT84624B (pt) Processo de preparacao de imidazois substituidos
ZA935647B (en) Treatment of sickle cell disease
PT94032A (pt) Processo de preparacao de betao betuminoso contendo pedacos de arame
ITMI910193A0 (it) Processo per la preparazione di peraloolefine
DK637389A (da) Plantebehandlingspraeparat
BR9304035A (pt) Processo de tratamento agroquimico de bananeiras
BR8705762A (pt) Processo de tratamento termico
ITMI931033A0 (it) Processo per la preparazione di gemfibrozil
BR9305837A (pt) Processo de preparação de 3-carbonilandrostadieno 17-carboxamidas
IT1227918B (it) Impianto per la depurazione meccanico-biologica di acque di rifiuto
BR8705793A (pt) Processo de tratamento de esterco
FR2600337B1 (fr) Procede de traitement d'os
ITMI910172A0 (it) Processo per la preparazione di perfluoro-ossiaziridine
NO924701D0 (no) Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal